By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Drug Company to Congress: The ‘Dog Ate My Homework’
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Drug Company to Congress: The ‘Dog Ate My Homework’
Medical Ethics

Drug Company to Congress: The ‘Dog Ate My Homework’

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

A decade ago WilmerHale, a powerful law firm, missed a key deadline far more important than homework. It mistakenly filed a patent extension for its drug company client one day after the 60-day deadline. Rather than being penalized one letter grade like in grade school, the patent extension was rejected by the Patent and Trademark Office, causing the client to lose patent protection five years early for a drug it owned. The drug company sued its law firm, which agreed to cough up $214 million if it cannot somehow reverse the Patent Office’s extension rejection. The powerful law firm and its client have been lobbying Congress to change the law ever since.

In an amendment that is derisively being called “The Dog Ate My Homework Act,” the House agreed to change the way the 60-day patent extension filing deadline is calculated – just to benefit this one powerful law firm and its client. The Senate takes up the debate this week. If this amendment passes, consumers will pay more and have slower access to generic drugs. Let’s hope Congress leaves the law intact rather than demonstrate that rules can be broken when they are inconvenient to powerful lobbying interests.

More Read

Dilemmas in Healthcare’s Information Age: A Bioethicist’s Take on EMRs, DNA Sequencing
Emergency Nurses: An Overabundance of Violence
Social Media Policies and “Spying” by Physicians
Drug Interaction Review and Tools for Caregivers
Bloggers and Social Media Risk
   

TAGGED:pharmaceuticalsWilmerHale
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

How Online Therapy Is Improving Mental Health Outcomes
Therapy
February 6, 2026
fight againt cancer
Breakthroughs in RNA Sequencing Provide New Insights in the Fight Against Cancer
Cancer News Specialties
February 1, 2026
aging in modern healthcare
Why Aging in Place Is Becoming a Cornerstone of Modern Healthcare
Global Healthcare Senior Care
January 29, 2026
Mental Health EHR
What Are the Core Features of a Mental Health EHR?
Mental Health Therapies
January 28, 2026

You Might also Like

healthcare expert
Health ReformNewsPolicy & LawPublic Health

Health Wonk Review: The Week’s Healthcare News

March 15, 2013

FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US

January 29, 2012

Komen Reverses Decision With Planned Parenthood

February 4, 2012

Who is Susceptible to the Placebo Effect?

November 24, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?